Abstract:Hypoxic pulmonary vascular remodelling (PVR) is the major pathological basis of aging-related chronic obstructive pulmonary disease and obstructive sleep apnea syndrome. The pulmonary artery endothelial cell (PAEC) inflammation, and pulmonary artery smooth muscle cell (PASMC) proliferation, hypertrophy and collagen remodelling are the important pathophysiological components of PVR. Endogenous sulfur dioxide (SO2) was found to be a novel gasotransmitter in the cardiovascular system with its unique biological properties. The study was aimed to investigate the role of endothelial cell- (EC-) derived SO2 in the progression of PAEC inflammation, PASMC proliferation, hypertrophy and collagen remodelling in PVR and the possible mechanisms. EC-specific aspartic aminotransferase 1 transgenic (EC-AAT1-Tg) mice were constructed in vivo. Pulmonary hypertension was induced by hypoxia. Right heart catheterization and echocardiography were used to detect mouse hemodynamic changes. Pathologic analysis was performed in the pulmonary arteries. High-performance liquid chromatography was employed to detect the SO2 content. Human PAECs (HPAECs) with lentiviruses containing AAT1 cDNA or shRNA and cocultured human PASMCs (HPASMCs) were applied in vitro. SO2 probe and enzyme-linked immunosorbent assay were used to detect the SO2 content and determine p50 activity, respectively. Hypoxia caused a significant reduction in SO2 content in the mouse lung and HPAECs and increases in right ventricular systolic pressure, pulmonary artery wall thickness, muscularization, and the expression of PAEC ICAM-1 and MCP-1 and of PASMC Ki-67, collagen I, and α-SMA ( p < 0.05 ). However, EC-AAT1-Tg with sufficient SO2 content prevented the above increases induced by hypoxia ( p < 0.05 ). Mechanistically, EC-derived SO2 deficiency promoted HPAEC ICAM-1 and MCP-1 and the cocultured HPASMC Ki-67 and collagen I expression, which was abolished by andrographolide, an inhibitor of p50 ( p < 0.05 ). Meanwhile, EC-derived SO2 deficiency increased the expression of cocultured HPASMC α-SMA ( p < 0.05 ). Taken together, these findings revealed that EC-derived SO2 inhibited p50 activation to control PAEC inflammation in an autocrine manner and PASMC proliferation, hypertrophy, and collagen synthesis in a paracrine manner, thereby inhibiting hypoxic PVR.

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension

SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner

Exacerbated Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Animals with Loss of Function of Extracellular Superoxide Dismutase.

Epigenetic Regulation of Pulmonary Arterial Hypertension

Extracellular Superoxide Dismutase Regulates Early Vascular Hyaluronan Remodeling in Hypoxic Pulmonary Hypertension

The relationship of superoxide dismutase and malondialdehyde levels with left ventricular geometry and function in patients with primary hypertension

Extracellular Superoxide Dismutase Is Associated With Left Ventricular Geometry and Heart Failure in Patients With Cardiovascular Disease

Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

SOD2 Ameliorates Pulmonary Hypertension in a Murine Model of Sleep Apnea Via Suppressing Expression of NLRP3 in CD11b+ Cells.

Proteomic Study Reveals Altered Carbamyl-Phosphate Synthetase I In Congenital Heart Disease-Associated Pulmonary Arterial Hypertension

Change of erythrocytic superoxide dismutase and lipid peroxidein of chronic pulmonary heart disease and its clinical significance Change of erythrocytic superoxide dismutase and lipid peroxidein of chronic pulmonary heart disease and its clinical significance

Abstract 14257: Endothelial SOX17 Deficiency Induces Pulmonary Arterial Hypertension

Endothelial Cell-Derived SO2 Controls Endothelial Cell Inflammation, Smooth Muscle Cell Proliferation, and Collagen Synthesis to Inhibit Hypoxic Pulmonary Vascular Remodelling

Heterozygous SOD2 Deletion Deteriorated Chronic Intermittent Hypoxia-Induced Lung Inflammation and Vascular Remodeling Through Mtros-Nlrp3 Signaling Pathway

Extracellular Superoxide Dismutase Protects the Heart Against Oxidative Stress and Hypertrophy after Myocardial Infarction.

Effect of Hydrogen Sulfide on Oxidative Stress in Hypoxic Pulmonary Hypertension

Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia

Abstract 13304: Sox17 Deficiency Induces Pulmonary Hypertension Through E2F1/BRD4 Signaling

Hydrogen Sulfide Regulates Lung Tissue-Oxidized Glutathione and Total Antioxidant Capacity in Hypoxic Pulmonary Hypertensive Rats

Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility